1-Methyl-4-piperidino-4-piperidincarboxamid | 36984-37-9

• 分子结构分类: 有机化合物 - 有机酸及其衍生物 - 羧酸及其衍生物
• 英文名称: 1-Methyl-4-piperidino-4-piperidincarboxamid
• 英文别名: 1-Methyl-4-piperidin-1-ylpiperidine-4-carboxamide
• CAS: 36984-37-9
• 化学式: C₁₂H₂₃N₃O
• 分子量: 225.334
• InChiKey: KVVXZEGFVFWIFG-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  0.2
• 重原子数：
  16
• 可旋转键数：
  2
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.92
• 拓扑面积：
  49.6
• 氢给体数：
  1
• 氢受体数：
  3

文献信息

• PYRROLE DERIVATIVES, PREPARATION THEREOF AND THERAPEUTIC USE THEREOF
  申请人：Barth Francis

  公开号：US20090281116A1

  公开（公告）日：2009-11-12

  The invention relates to compounds having the formula (I): Wherein R 1 , R 2 , R 3 , R 4 , R 5 , R 6 , R 7 and R 9 and A-R 9 are as defined herein. Also disclosed are the preparative methods for the compounds of formula (I) and their use in therapy.

  这项发明涉及具有以下结构式（I）的化合物：其中R1、R2、R3、R4、R5、R6、R7和R9以及A-R9如本文所定义。还披露了结构式（I）化合物的制备方法以及它们在治疗中的用途。
• PYRROLE DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION
  申请人：Barth Francis

  公开号：US20110152320A1

  公开（公告）日：2011-06-23

  The subject of the invention is compounds of formula (I): in which R 1 -R 10 are as defined within, the method of preparation and therapeutic application as cannabinoid CB1 receptor antagonists.

  本发明的主题是公式（I）的化合物： 其中R1-R10如定义，制备方法和治疗应用作为大麻素CB1受体拮抗剂。
• PYRROLE DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC USE
  申请人：Barth Francis

  公开号：US20070149596A1

  公开（公告）日：2007-06-28

  The invention concerns compounds of formula (I): Wherein R 1 , R 2 , R 3 , R 4 , R 5 , R 6 , R 7 , R 8 and R 9 are as defined herein. The invention also concerns the method for preparing said compounds and their therapeutic use.

  该发明涉及式(I)的化合物：其中R1、R2、R3、R4、R5、R6、R7、R8和R9如本文所定义。该发明还涉及制备所述化合物的方法及其治疗用途。
• OXAZOLE DERIVATIVES, PREPARATION AND THERAPEUTIC USE THEREOF
  申请人：BARTH Francis

  公开号：US20070043060A1

  公开（公告）日：2007-02-22

  This invention relates to compounds of formula (I): Wherein R 1 , R 2 , R 3 , R 4 , R 5 , R 6 , R 7 and R 8 are as described herein. The invention further relates to a method for prevention and therapeutic use thereof.

  本发明涉及式(I)化合物：其中R1、R2、R3、R4、R5、R6、R7和R8如本文所述。本发明还涉及其预防和治疗用途的方法。
• DERIVES DE PYRROLE, LEUR PREPARATION ET LEUR UTILISATION EN THERAPEUTIQUE.
  申请人：SANOFI

  公开号：EP2094656B1

  公开（公告）日：2011-08-17